Stocks · Health care · Pharmaceutical Preparations

Opus Genetics, Inc.

IRD Clue Score33
United States Fiscal year ends December CIK 0001228627 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George Magrath
9 Sep 2026
Chief Executive Officer
Exercised, kept
392,157
$1.15
$450.98K
Cam Gallagher
8 Sep 2026
Director
Exercised, kept
784,314
$1.15
$901.96K
Cam Gallagher
4 Jan 2023
Director
Exercised, kept
1,574
$0.00
$0.16
Sean Ainsworth
19 Oct 2022
Director
Exercised, kept
1,574
$0.00
$0.16
James S J Manuso
11 Oct 2022
Director
Exercised, kept
787
$0.00
$0.08
Richard J Rodgers
3 Oct 2022
Director
Exercised, kept
3,148
$0.00
$0.31
Mina Sooch
6 Sep 2022
President and CEO
Exercised, kept
1,023
$0.00
$0.10

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 23
Transactions with no price 6
Shares from compensation/vesting 18,098,737
History held since 8 Jan 2007